NCT07447011Recruiting
Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 26 Feb 2026
- Start date
- Feb 2026
- Primary completion date
- Jul 2026
- Lead sponsor
- Cairo University
- NCT number
- NCT07447011
What you commit to
- Study type: Interventional
- Planned participants: 40
- From Feb 2026 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- cardiac patients renal patients hepatic patients
Who the study is looking for
- Obstructive sleep apnea patients
- obese patients
- glaucoma (open angle form with ocular hyoertension)
Age in the registry: 30 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Coordinator of this site? Confirm its status | Giza | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.